Literature DB >> 34389623

Th22 Cells Are a Major Contributor to the Mycobacterial CD4+ T Cell Response and Are Depleted During HIV Infection.

Rubina Bunjun1,2, Fidilia M A Omondi1,2, Mohau S Makatsa1,2, Roanne Keeton1,2, Jerome M Wendoh1,2, Tracey L Müller1,2, Caryn S L Prentice1,2, Robert J Wilkinson1,3,4,5,6, Catherine Riou1,2,3, Wendy A Burgers7,2,3.   

Abstract

HIV-1 infection substantially increases the risk of developing tuberculosis (TB). Mechanisms such as defects in the Th1 response to Mycobacterium tuberculosis in HIV-infected persons have been widely reported. However, Th1-independent mechanisms also contribute to protection against TB. To identify a broader spectrum of defects in TB immunity during HIV infection, we examined IL-17A and IL-22 production in response to mycobacterial Ags in peripheral blood of persons with latent TB infection and HIV coinfection. Upon stimulating with mycobacterial Ags, we observed a distinct CD4+ Th lineage producing IL-22 in the absence of IL-17A and IFN-γ. Mycobacteria-specific Th22 cells were present at high frequencies in blood and contributed up to 50% to the CD4+ T cell response to mycobacteria, comparable in magnitude to the IFN-γ Th1 response (median 0.91% and 0.55%, respectively). Phenotypic characterization of Th22 cells revealed that their memory differentiation was similar to M. tuberculosis-specific Th1 cells (i.e., predominantly early differentiated CD45RO+CD27+ phenotype). Moreover, CCR6 and CXCR3 expression profiles of Th22 cells were similar to Th17 cells, whereas their CCR4 and CCR10 expression patterns displayed an intermediate phenotype between Th1 and Th17 cells. Strikingly, mycobacterial IL-22 responses were 3-fold lower in HIV-infected persons compared with uninfected persons, and the magnitude of responses correlated inversely with HIV viral load. These data provide important insights into mycobacteria-specific Th subsets in humans and suggest a potential role for IL-22 in protection against TB during HIV infection. Further studies are needed to fully elucidate the role of IL-22 in protective TB immunity.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34389623      PMCID: PMC8387408          DOI: 10.4049/jimmunol.1900984

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  87 in total

Review 1.  The crucial roles of Th17-related cytokines/signal pathways in M. tuberculosis infection.

Authors:  Hongbo Shen; Zheng W Chen
Journal:  Cell Mol Immunol       Date:  2017-11-27       Impact factor: 11.530

2.  Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung.

Authors:  Yuko Okamoto Yoshida; Masayuki Umemura; Ayano Yahagi; Rebecca L O'Brien; Koichi Ikuta; Kenji Kishihara; Hiromitsu Hara; Susumu Nakae; Yoichiro Iwakura; Goro Matsuzaki
Journal:  J Immunol       Date:  2010-03-08       Impact factor: 5.422

Review 3.  A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes.

Authors:  W M El-Sadr; D C Perlman; E Denning; J P Matts; D L Cohn
Journal:  Clin Infect Dis       Date:  2001-02-09       Impact factor: 9.079

4.  Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype.

Authors:  Catherine Riou; Ramla F Tanko; Andreia P Soares; Lindi Masson; Lise Werner; Nigel J Garrett; Natasha Samsunder; Quarraisha Abdool Karim; Salim S Abdool Karim; Wendy A Burgers
Journal:  J Immunol       Date:  2015-07-20       Impact factor: 5.422

Review 5.  IL-22: a critical mediator in mucosal host defense.

Authors:  S J Aujla; J K Kolls
Journal:  J Mol Med (Berl)       Date:  2009-02-14       Impact factor: 4.599

6.  IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion.

Authors:  Rohan Dhiman; Mohanalaxmi Indramohan; Peter F Barnes; Ramesh C Nayak; Padmaja Paidipally; L Vijaya Mohan Rao; Ramakrishna Vankayalapati
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

7.  Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands.

Authors:  Yelina Alvarez; Michael Tuen; Guomiao Shen; Fatima Nawaz; James Arthos; Martin J Wolff; Michael A Poles; Catarina E Hioe
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

8.  Bronchoalveolar CD4+ T cell responses to respiratory antigens are impaired in HIV-infected adults.

Authors:  Kondwani C Jambo; Enoch Sepako; Duncan G Fullerton; David Mzinza; Sarah Glennie; Adam K Wright; Robert S Heyderman; Stephen B Gordon
Journal:  Thorax       Date:  2011-02-25       Impact factor: 9.139

9.  Transcriptional profiling of disease-induced host responses in bovine tuberculosis and the identification of potential diagnostic biomarkers.

Authors:  Elihu Aranday-Cortes; Philip J Hogarth; Daryan A Kaveh; Adam O Whelan; Bernardo Villarreal-Ramos; Ajit Lalvani; H Martin Vordermeier
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

10.  Effect of HIV on the Frequency and Number of Mycobacterium tuberculosis-Specific CD4+ T Cells in Blood and Airways During Latent M. tuberculosis Infection.

Authors:  Rubina Bunjun; Catherine Riou; Andreia P Soares; Narjis Thawer; Tracey L Müller; Agano Kiravu; Zekarias Ginbot; Tolu Oni; Rene Goliath; Barbara Kalsdorf; Florian von Groote-Bidlingmaier; Willem Hanekom; Gerhard Walzl; Robert J Wilkinson; Wendy A Burgers
Journal:  J Infect Dis       Date:  2017-12-19       Impact factor: 5.226

View more
  1 in total

1.  Characterization of Mycobacterium tuberculosis-Specific Th22 Cells and the Effect of Tuberculosis Disease and HIV Coinfection.

Authors:  Mohau S Makatsa; F Millicent A Omondi; Rubina Bunjun; Robert J Wilkinson; Catherine Riou; Wendy A Burgers
Journal:  J Immunol       Date:  2022-07-01       Impact factor: 5.426

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.